416 results on '"Stoffels, G."'
Search Results
2. Fast and accurate water content and T2⁎ mapping in brain tumours localised with FET-PET
3. Incidence and Risk Factors for 30 Day Reoperation in Benign Hysterectomy
4. P01.01.A Lesion-Function Analysis from Multimodal Imaging and Normative Brain Atlases for Prediction of Cognitive Deficits in Glioma Patients
5. P01.02.B Case Report: Disruption of Resting-State Networks and Cognitive Deficits After Whole Brain Irradiation for Singular Brain Metastasis
6. KS05.5.A Alterations in white matter fiber density associated with structural MRI and metabolic PET lesions following multimodal therapy in glioma patients
7. LESION-FUNCTION ANALYSIS FROM MULTIMODAL IMAGING AND NORMATIVE BRAIN ATLASES FOR PREDICTION OF COGNITIVE DEFICITS IN GLIOMA PATIENTS
8. CASE REPORT: DISRUPTION OF RESTING-STATE NETWORKS AND COGNITIVE DEFICITS AFTER WHOLE BRAIN IRRADIATION FOR SINGULAR BRAIN METASTASIS
9. ALTERATIONS IN WHITE MATTER FIBER DENSITY ASSOCIATED WITH STRUCTURAL MRI AND METABOLIC PET LESIONS FOLLOWING MULTIMODAL THERAPY IN GLIOMA PATIENTS
10. Perioperative complications after reconstructive surgery for pelvic organ prolapse in patients with diabetes: analysis of a national database
11. A compact active grid for stirring pipe flow
12. In-Cylinder Measurements of NO Formation in a Diesel Engine
13. POSTER ABSTRACTS
14. OS03.3.A Characterization of long-term metabolic changes of irradiated brain metastases using serial dynamic FET PET imaging
15. Lesion-Function Analysis from Multimodal Imaging and Normative Brain Atlases for Prediction of Cognitive Deficits in Glioma Patients
16. Integrated boost IMRT with FET-PET-adapted local dose escalation in glioblastomas: Results of a prospective phase II study
17. Evaluation of new 18F-labeled amino acids for brain PET
18. Diagnosis of pseudoprogression following lomustine-temozolomide chemoradiation in newly diagnosed glioblastoma patients using FET PET
19. The Role of Radionuclide Diagnostic Methods in Neuro-Oncology
20. Imaging findings following regorafenib in malignant gliomas: FET PET adds valuable information to anatomical MRI
21. Einfluss des regionalen Blutvolumens auf die Zeitaktivitätskurve der FET-Anreicherung von Hirntumoren
22. The T2-FLAIR mismatch sign in IDH-mutant astrocytomas - Is there an association with FET PET uptake?
23. Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[ 18 F]-fluoroethyl)-L-tyrosine PET
24. Stereotaktische Koregistrierung von Sprachaktivierung und Aminosäure-Markierung bei Patienten mit linkshemisphärischen Hirntumoren
25. Strahlentherapie hochmaligner Gliome - Analyse der prognostischen Aussagekraft des prätherapeutischen O-(2-[18F]Fluorethyl)-L-Tyrosin- (FET-) PET: FV303
26. Imaging of an underexpanded nozzle flow by UV laser Rayleigh scattering
27. The blood pressure response to chronic sibutramine treatment in obese subjects is related to sympathetic activity: OP0030
28. Role of the default mode resting-state network for cognitive functioning in malignant glioma patients following multimodal treatment
29. Purification and characterization of a new bacteriocin isolated from Carnobacterium sp
30. Use of FET PET in glioblastoma patients undergoing neurooncological treatment including tumor-treating fields: Initial experiences
31. P14.29 Prediction of overall survival in patients with malignant glioma using dynamic O-(2-[18F]-fluoroethyl)-L-tyrosine PET
32. P04.07 Correlation of 18F-fluorethyl-L-tyrosine (18F-FET) uptake in positron emission tomography (PET) and MRI growth rate in low-grade glioma
33. P14.17 Differentiation of treatment-related changes from tumor progression: A direct comparison between dynamic FET PET and ADC values obtained from DWI MRI
34. P14.18 Prognostic value of serial dynamic O-(2-[18F]-fluoroethyl)-L-tyrosine PET in patients with non-resectable malignant glioma undergoing chemoradiation
35. Combined FET PET/MRI radiomics differentiates radiation injury from recurrent brain metastasis
36. Differentiation of treatment-related changes from high-grade glioma progression: A direct comparison between FET PET and ADC values obtained by DWI MRI
37. Comparison of [18F]-Fluoroethyltyrosine PET and the IDH status with Sodium MRI in Cerebral Gliomas
38. POSTER ABSTRACTS: P20 ADJUVANT MISOPROSTOL OR MIFEPRISTONE FOR CERVICAL PREPARATION WITH OSMOTIC DILATORS BEFORE DILATION AND EVACUATION
39. P05.11 Combined FET PET/MRI radiomics for the differentiation of radiation injury from recurrent brain metastasis
40. COMBINED FET PET/MRI RADIOMICS FOR THE DIFFERENTIATION OF RADIATION INJURY FROM RECURRENT BRAIN METASTASIS
41. Assessment of pseudoprogression in primary and secondary GBM using FET PET and molecular genetics
42. Navigated transcranial magnetic stimulation in perirolandic cerebral metastases as compared to matched high-grade gliomas: Functional outcome and impact upon the extent of resection
43. Fluid volume at 12 hours is associated with outcomes in acute pancreatitis: A retrospective study
44. P09.26 FET PET radiomics - diagnosis of pseudoprogression in glioblastoma patients based on textural features
45. P10.17 Predicting isocitrate dehydrogenase genotype in malignant glioma using FET PET radiomics
46. PREDICTING ISOCITRATE DEHYDROGENASE GENOTYPE IN MALIGNANT GLIOMA USING FET PET RADIOMICS
47. FET PET RADIOMICS - DIAGNOSIS OF PSEUDOPROGRESSION IN GLIOBLASTOMA PATIENTS BASED ON TEXTURAL FEATURES
48. Klinisch-pharmakologische Untersuchungen über die Arzneimittelresorption bei Lebererkrankungen
49. Multimodal Imaging in Malignant Brain Tumors: Enhancing the Preoperative Risk Evaluation for Motor Deficits with a Combined Hybrid MRI-PET and Navigated Transcranial Magnetic Stimulation Approach
50. TREATMENT RESPONSE EVALUATION USING 18F-FET PET IN GLIOBLASTOMA PATIENTS AT FIRST RECURRENCE TREATED WITH A COMBINATION OF BEVACIZUMAB PLUS LOMUSTINE
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.